BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38722955)

  • 1. Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.
    Vermehren-Schmaedick A; Peto M; Wagoner W; Chiotti KE; Ramsey E; Wang X; Rakshe S; Minnier J; Sears R; Spellman P; Luoh SW
    PLoS One; 2024; 19(5):e0302856. PubMed ID: 38722955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.
    Pan B; Ren H; Lv X; Zhao Y; Yu B; He Y; Ma Y; Niu C; Kong J; Yu F; Sun WB; Zhang Y; Willard B; Zheng L
    J Transl Med; 2012 Mar; 10():65. PubMed ID: 22462581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.
    Zhou B; Gibson-Corley KN; Herndon ME; Sun Y; Gustafson-Wagner E; Teoh-Fitzgerald M; Domann FE; Henry MD; Stipp CS
    Mol Cancer Res; 2014 Jan; 12(1):143-154. PubMed ID: 24002891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis.
    Kusuma N; Denoyer D; Eble JA; Redvers RP; Parker BS; Pelzer R; Anderson RL; Pouliot N
    Int J Cancer; 2012 Feb; 130(3):555-66. PubMed ID: 21387294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
    Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
    Smith YE; Toomey S; Napoletano S; Kirwan G; Schadow C; Chubb AJ; Mikkelsen JH; Oxvig C; Harmey JH
    BMC Cancer; 2018 Oct; 18(1):1016. PubMed ID: 30348128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
    Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
    Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF13 promotes metastasis of triple-negative breast cancer.
    Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
    Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
    Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
    BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
    Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
    J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted regulation of Rell2 by microRNA-18a is implicated in the anti-metastatic effect of polyphyllin VI in breast cancer cells.
    Wang P; Yang Q; Du X; Chen Y; Zhang T
    Eur J Pharmacol; 2019 May; 851():161-173. PubMed ID: 30817902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
    Pei S; Yang X; Wang H; Zhang H; Zhou B; Zhang D; Lin D
    BMC Cancer; 2015 Dec; 15():965. PubMed ID: 26674531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.
    Sharp JA; Waltham M; Williams ED; Henderson MA; Thompson EW
    Clin Exp Metastasis; 2004; 21(1):19-29. PubMed ID: 15065599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.
    Hiraga T; Williams PJ; Ueda A; Tamura D; Yoneda T
    Clin Cancer Res; 2004 Jul; 10(13):4559-67. PubMed ID: 15240548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of GTPase activating protein Git2 on metastasis in breast cancer].
    Zhou W; Cao MG; Xu J; Fang ZY; Wang XY; Guo ZP; Li SS; Zhou ZH
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):492-8. PubMed ID: 27531261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
    Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
    Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.